These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 24722527)

  • 21. Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents.
    Lazar L; Lebenthal Y; Steinmetz A; Yackobovitch-Gavan M; Phillip M
    J Pediatr; 2009 May; 154(5):708-14. PubMed ID: 19167722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric Differentiated Thyroid Carcinoma in The Netherlands: A Nationwide Follow-Up Study.
    Klein Hesselink MS; Nies M; Bocca G; Brouwers AH; Burgerhof JG; van Dam EW; Havekes B; van den Heuvel-Eibrink MM; Corssmit EP; Kremer LC; Netea-Maier RT; van der Pal HJ; Peeters RP; Schmid KW; Smit JW; Williams GR; Plukker JT; Ronckers CM; van Santen HM; Tissing WJ; Links TP
    J Clin Endocrinol Metab; 2016 May; 101(5):2031-9. PubMed ID: 26963949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Differentiated thyroid carcinoma, 1972-1992. Follow-up, detection of recurrences and prognostic factors].
    Obiols G; Simó R; Burgos R; Tresserras R; Galofré P; Masmiquel L; Hernández C; Mesa J
    Med Clin (Barc); 1997 Nov; 109(19):738-43. PubMed ID: 9470182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
    Krajewska J; Jarząb M; Czarniecka A; Roskosz J; Kukulska A; Handkiewicz-Junak D; Puch Z; Wygoda Z; Paliczka-Cieślik E; Kropińska A; Gubała E; Jurecka-Lubieniecka B; Jarząb B
    Endokrynol Pol; 2016; 67(1):2-11. PubMed ID: 26884109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid cancer in pediatric age group: an institutional experience and review of the literature.
    Kiratli PO; Volkan-Salanci B; Günay EC; Varan A; Akyüz C; Büyükpamukçu M
    J Pediatr Hematol Oncol; 2013 Mar; 35(2):93-7. PubMed ID: 23128335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiated thyroid cancer in patients over 60 years of age at presentation: a retrospective study of 438 patients.
    Garg A; Chopra S; Ballal S; Soundararajan R; Bal CS
    J Geriatr Oncol; 2015 Jan; 6(1):29-37. PubMed ID: 25287965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastatic differentiated thyroid carcinoma: clinical management and outcome of disease in patients with initial and late distant metastases.
    Mihailovic JM; Stefanovic LJ; Malesevic MD; Erak MD; Tesanovic DD
    Nucl Med Commun; 2009 Jul; 30(7):558-64. PubMed ID: 19436230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
    McHenry C; Jarosz H; Lawrence AM; Paloyan E
    Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low-risk well-differentiated thyroid cancer.
    Tsirona S; Vlassopoulou V; Tzanela M; Rondogianni P; Ioannidis G; Vassilopoulos C; Botoula E; Trivizas P; Datseris I; Tsagarakis S
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):459-63. PubMed ID: 23895145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.
    Lee J; Soh EY
    Ann Surg; 2010 Jan; 251(1):114-9. PubMed ID: 19779325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases.
    Bal CS; Garg A; Chopra S; Ballal S; Soundararajan R
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):745-51. PubMed ID: 25210762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients.
    Castagna MG; Cevenini G; Theodoropoulou A; Maino F; Memmo S; Claudia C; Belardini V; Brianzoni E; Pacini F
    Eur J Endocrinol; 2013 Jul; 169(1):23-9. PubMed ID: 23594687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation.
    Vianello F; Mazzarotto R; Mian C; Lora O; Saladini G; Servodio O; Basso M; Pennelli G; Pelizzo MR; Sotti G
    Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):162-8. PubMed ID: 21411300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
    Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
    Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
    Scheffel RS; Zanella AB; Dora JM; Maia AL
    Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
    La Quaglia MP; Black T; Holcomb GW; Sklar C; Azizkhan RG; Haase GM; Newman KD
    J Pediatr Surg; 2000 Jun; 35(6):955-9; discussion 960. PubMed ID: 10873043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment patterns of aging Americans with differentiated thyroid cancer.
    Park HS; Roman SA; Sosa JA
    Cancer; 2010 Jan; 116(1):20-30. PubMed ID: 19908255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Factors for Early and Long-Term Remission in Pediatric Differentiated Thyroid Carcinoma: The Role of Sex, Age, Clinical Presentation, and the Newly Proposed American Thyroid Association Risk Stratification System.
    Pires BP; Alves PA; Bordallo MA; Bulzico DA; Lopes FP; Farias T; Dias F; Lima RA; Santos Gisler IC; Coeli CM; Carvalhaes de Oliveira RV; Corbo R; Vaisman M; Vaisman F
    Thyroid; 2016 Oct; 26(10):1480-1487. PubMed ID: 27540892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.